PAR PHARM INC FDA Approval ANDA 209509

ANDA 209509

PAR PHARM INC

FDA Drug Application

Application #209509

Application Sponsors

ANDA 209509PAR PHARM INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0AMBRISENTANAMBRISENTAN
002TABLET;ORAL10MG0AMBRISENTANAMBRISENTAN

FDA Submissions

UNKNOWN; ORIG1AP2019-04-10STANDARD
REMS; REMSSUPPL2AP2020-12-22
REMS; REMSSUPPL4AP2021-06-08

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL4Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

PAR PHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209509
            [companyName] => PAR PHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMBRISENTAN","activeIngredients":"AMBRISENTAN","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"AMBRISENTAN","activeIngredients":"AMBRISENTAN","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/10\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"06\/08\/2021","submission":"SUPPL-4","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/22\/2020","submission":"SUPPL-2","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"11\/29\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2021-06-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.